Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Read more UK Legal Status Dihexa's position under UK law: not controlled, not licensed as a medicine, sold as a research chemical
Reconstitution note (for research-grade GHK-Cu powder): GHK-Cu is typically soluble in water at neutral pH
Why This Combination Is Theoretically Interesting Combining cagrilintide with tirzepatide would theoretically offer: Triple mechanism activation across complementary metabolic pathways Enhanced satiety signaling through multiple central and peripheral mechanisms Synergistic weight loss potential exceeding single or dual-pathway approaches Comprehensive glycemic control for those with metabolic dysfunction Multiple points of intervention in the appetite-regulation system Current Clinical Evidence Limitations As of 2026, no approved or extensively studied protocol exists specifically for cagrilintide dosage with tirzepatide
Hippo pathway activation in aged mesenchymal stem cells contributes to the dysregulation of hepatic inflammation in aged mice
Visible particles mean the peptide has crashed out of solution
US$ 25.25
US$ 21.05
US$ 21.66
US$ 26.15
US$ 28.70
US$ 28.41
US$ 29.11
US$ 21.14
US$ 22.18
US$ 21.81
US$ 26.95
US$ 26.51
US$ 20.30
US$ 24.77
US$ 24.32
US$ 19.99
